127 related articles for article (PubMed ID: 33358904)
1. Transcriptome analysis evinces anti-neoplastic mechanisms of hypericin: A study on U87 glioblastoma cell line.
Ghiasvand S; Javidi MA; Mohammadian A; Mousavi SA; Shahriari F; Alavian F
Life Sci; 2021 Feb; 266():118874. PubMed ID: 33358904
[TBL] [Abstract][Full Text] [Related]
2. Unique anti-glioblastoma activities of hypericin are at the crossroad of biochemical and epigenetic events and culminate in tumor cell differentiation.
Dror N; Mandel M; Lavie G
PLoS One; 2013; 8(9):e73625. PubMed ID: 24066060
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
4. Diazepam enhances hypericin-induced photocytotoxicity and apoptosis in human glioblastoma cells.
Sarissky M; Lavicka J; Kocanová S; Sulla I; Mirossay A; Miskovsky P; Gajdos M; Mojzis J; Mirossay L
Neoplasma; 2005; 52(4):352-9. PubMed ID: 16059654
[TBL] [Abstract][Full Text] [Related]
5. Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8.
Schempp CM; Simon-Haarhaus B; Termeer CC; Simon JC
FEBS Lett; 2001 Mar; 493(1):26-30. PubMed ID: 11277999
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance.
Motaln H; Koren A; Gruden K; Ramšak Ž; Schichor C; Lah TT
Oncotarget; 2015 Dec; 6(38):40998-1017. PubMed ID: 26517510
[TBL] [Abstract][Full Text] [Related]
7. Physiological and Transcriptomic Analysis Provide Insight into Low Temperature Enhancing Hypericin Biosynthesis in
Su H; Li J; Chen S; Sun P; Xing H; Yang D; Zhang X; Li M; Wei J
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921038
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
[TBL] [Abstract][Full Text] [Related]
9. Primary glioblastoma transcriptome data analysis for screening survival-related genes.
Yang Y; Yan R; Zhang L; Meng X; Sun W
J Cell Biochem; 2020 Feb; 121(2):1901-1910. PubMed ID: 31633244
[TBL] [Abstract][Full Text] [Related]
10. Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas.
Karki K; Li X; Jin UH; Mohankumar K; Zarei M; Michelhaugh SK; Mittal S; Tjalkens R; Safe S
J Neurooncol; 2020 Jan; 146(1):25-39. PubMed ID: 31754919
[TBL] [Abstract][Full Text] [Related]
11. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
12. Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma.
Cho HJ; Zhao J; Jung SW; Ladewig E; Kong DS; Suh YL; Lee Y; Kim D; Ahn SH; Bordyuh M; Kang HJ; Sa JK; Seo YJ; Kim ST; Lim DH; Dho YS; Lee JI; Seol HJ; Choi JW; Park WY; Park CK; Rabadan R; Nam DH
Neuro Oncol; 2019 Jan; 21(1):47-58. PubMed ID: 30085274
[TBL] [Abstract][Full Text] [Related]
13. Novel CXCR4 Inhibitor CPZ1344 Inhibits the Proliferation, Migration and Angiogenesis of Glioblastoma.
Luo Z; Wang B; Chen Y; Liu H; Shi L
Pathol Oncol Res; 2020 Oct; 26(4):2597-2604. PubMed ID: 32632898
[TBL] [Abstract][Full Text] [Related]
14. Hypericin Induces Apoptosis in MDA-MB-175-VII Cells in Lower Dose Compared to MDA-MB-231.
Abbasi Gamasaee N; Radmansouri M; Ghiasvand S; Shahriari F; Zare Marzouni H; Aryan H; Jangholi E; Javidi MA
Arch Iran Med; 2018 Sep; 21(9):387-392. PubMed ID: 30221528
[TBL] [Abstract][Full Text] [Related]
15. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
[TBL] [Abstract][Full Text] [Related]
16. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
17. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
18. Cell death response of U87 glioma cells on hypericin photoactivation is mediated by dynamics of hypericin subcellular distribution and its aggregation in cellular organelles.
Huntosova V; Nadova Z; Dzurova L; Jakusova V; Sureau F; Miskovsky P
Photochem Photobiol Sci; 2012 Sep; 11(9):1428-36. PubMed ID: 22729350
[TBL] [Abstract][Full Text] [Related]
19. Study on the Inhibitory Effect of Curcumin on GBM and Its Potential Mechanism.
Su X; Chen S; Lu H; Li H; Qin C
Drug Des Devel Ther; 2021; 15():2769-2781. PubMed ID: 34234410
[TBL] [Abstract][Full Text] [Related]
20. Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
DNA Cell Biol; 2019 Jul; 38(7):688-699. PubMed ID: 31188028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
